Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


Latest News

Date posted: 12/12/2013

Authored by Chris Schroeder

Merck’s NuvaRing contraceptive insert was approved by the FDA in 2001 and launched in the United States in 2002. In the decade since, it has been used by millions of women and is now available in 32 countries.
Developed by Merck subsidiary Organon, NuvaRing is marketed as a safe, effective and convenient alternative to the daily pill with low hormone doses. Last year, Merck earned $623 million just from NuvaRing.
Unfortunately, recent studies and court records show there may be severe side effects of NuvaRing. Thousands of women have reported blood clots, deep vein thrombosis (DVT), pulmonary embolism or stroke while using the device. Some victims have even died.
While there is no class action lawsuit against NuvaRing, a federal panel has created a special multidistrict litigation court to handle the growing number of individual lawsuits, and trials are expected to start next year.
If you’ve asked, “Should I file a NuvaRing lawsuit?” it’s important to speak with a lawyer about your options.
In 2012, researchers in the Netherlands concluded a study which found women using contraceptive rings like NuvaRing had 6 times the rate of blood clot injuries than those using no hormonal contraceptive.
The FDA has discovered women using NuvaRing over progestin-based hormonal birth control pills have a 56% higher risk of blood clots. The agency has also received more than 5,500 reports of patients suffering blood clot complications while using the device. However, they have no plans to recall NuvaRing or restrict its use.
A recent report claims NuvaRing was launched after a test involving only 16 women, Organon study No. 34218. Now, Merck faces liability for their failure to properly test the drug or warn patients of these dangers.
The latest NuvaRing lawsuit update 2013 court records show 1,563 people have filed claims in the federal MDL court and hundreds more are pending in a New Jersey state court. One of these involves Erika Langhart, a 24-year-old woman who died of a pulmonary embolism in 2011. The most recent court order scheduled trials to start this April.
Lawyers are urging anyone affected by blood clots after using NuvaRing to learn their legal options before time expires. If you suffered a stroke, DVT or pulmonary embolism, speak with a lawyer today.
DrugRisk cautions that lawsuits involving defective drug injuries can be very complex, therefore it is important to choose a lawyer who specializes in these types of cases. We only recommend lawyers who have handled NuvaRing lawsuits.
Contact us today for more information on the research, side effects and litigation related to NuvaRing, or to speak with a lawyer.